Background and Purpose: Despite the availability of various treatments for fungal diseases, there are some limitations in the management of these conditions due to multiple treatment-related side-effects. The present study was designed to investigate the antifungal properties of different extracts from Pistacia atlantica Desf. Materials and Methods: Different parts of P. atlantica (i.e., dried fruit, fresh fruit and dried leaf) were separately extracted via percolation method with 80% methanol and water. Gas chromatography/mass spectrometry (GC/MS) analysis was performed to determine the main constituents of leaf and fruit extracts from P. atlantica. In vitro antiCandida activities of the extracts against Candida albicans, Candida glabrata and Saccharomyces cerevisiae were studied. For this purpose, the minimum inhibitory concentrations (MICs) and minimum fungicidal concentrations (MFCs) were determined, using broth microdilution method, according to the modified M27-A3 protocol on yeasts, proposed by the Clinical and Laboratory Standards Institute (CLSI). Results: Based on GC/MS analysis, the main constituents of P. atlantica fruit extracts were β-myrcene (41.4%), α-pinene (32.48%) and limonene (4.66%), respectively, whereas the major constituents of P. atlantica leaf extracts were trans-caryophyllene (15.18%), α-amorphene (8.1%) and neo-allo-ocimene (6.21%), respectively. As the findings indicated, all the constituents exhibited both fungistatic and fungicidal activities, with MICs ranging from 6.66 to 26.66 mg/mL and MFCs ranging from 13.3 to 37.3 mg/mL, respectively. Among the evaluated extracts, the methanolic fresh fruit extract of P. atlantica was significantly more effective than other extracts (P<0.05). Conclusion: Based on the findings of the present study, novel antifungal agents need to be developed, and use of P. atlantica should be promoted in the traditional treatment of Candida infections.
Introduction
oday, the incidence of fungal infections is rising, considering the increased vulnerability of immunocompromised individuals, including patients with organ transplants, cancer and HIV/AIDS [1] . Candidiasis is a fungal infection caused by yeasts belonging to the genus Candida. Over the past three decades, Candida species have emerged as an important cause of opportunistic and healthcare-associated infections [2] .
Candida albicans has been introduced as the most prevalent pathogen in systemic fungal infections [3] . On the other hand, other Candida species account for more than 50% of fungal infections [3] . Saccharomyces cerevisiae is being increasingly reported as an agent of invasive infection, particularly in immunecompromised or critically ill patients. Therefore, this organism should be included in the growing list of emerging fungal pathogens [4] .
The available treatments for fungal diseases are diverse and numerous. However, only a few classes of antifungal agents are currently available for the treatment of yeast infections due to their high toxicity, emergence of drug resistance, pharmacokinetic deficiencies and/or T insufficient antifungal activities [5, 6] . Therefore, there is an urgent need for the development of novel, effective treatment alternatives.
Due to limited side-effects, low cost and extensive availability, plant extracts and plant-derived compounds are valuable sources, which are commonly used for the treatment of a variety of conditions including infectious diseases [7] . The genus Pistacia belongs to the family Anacardiaceae. Among 15 known species of pistachios, only three grow in Iran, including P. vera, P. khinjuk and P. atlantica [8] .
For the past 3000 years, P. atlantica Desf. has commonly grown in the Mediterranean and Middle Eastern countries. This plant, regionally known as "Baneh", grows in the central, Western and Eastern areas of Iran [9] . Different parts of this plant, including the resin, leaf, bark, fruit and aerial parts, have been widely used as traditional medicines for the treatment of various conditions such as gastrointestinal, respiratory, cutaneous, renal and infectious diseases. Moreover, previous studies have indicated the anti-inflammatory, antioxidant, anti-tumor, anti-asthmatic and antimicrobial properties of this plant [9] .
To the best of our knowledge, no previous research has focused on the anti-Candida activities of different parts of P. atlantica. Therefore, in this study, we aimed to evaluate the chemical composition and in vitro antifungal activities of various leaf and fruit extracts from P. atlantica against C. albicans, C. glabrata and S. cerevisiae.
Material and Methods

Chemical substances
The crude powder of miconazole (MZ) as the control agent was purchased from SigmaAldrich, St Louis, MO, USA. RPMI-1640 medium, l-glutamine and Sabouraud dextrose agar (SDA) were purchased from SigmaAldrich Co. (St. Louis, MO, USA). Also, potato dextrose agar (PDA) was obtained from Oxoid Ltd. (Basingstoke, Hampshire, UK). In addition, chloramphenicol and cycloheximide were purchased from Merck, Germany. All other chemicals and solvents were of an analytical grade.
Extract preparation
For extract preparation, 10 g of the powdered plant materials (i.e., dried fruit, fresh fruit and dried leaf) was separately and successively extracted through the percolation method with 80% methanol and water for 72 h at room temperature. The extracts were passed through a filter paper (Whatman No. 3, SigmaAldrich Co., Germany) to remove the plant debris. The extracts were finally vacuumconcentrated at 50 °C, using a rotary evaporator (Heidolph, Germany) and stored at -20 °C until use [10] .
Gas chromatography/mass spectrometry (GC/MS) analysis of the extracts
The chemical components of P. atlantica extracts were identified via extraction, using the solid-phase microextraction (SPME) technique. Initially, the samples were ground into a fine powder, using a household mill. Two grams of the samples were weighed and transferred to a 20 ml vial. Afterwards, the vial containing the sample was transferred to an ultrasonic device for extracting the volatile substances. The temperature of the ultrasonic device was set at 50 °C for 15 min.
In the next step, the SPME fiber was placed on the upper surface of the sample for 40 min to extract the volatile compounds. Immediately after the extraction, the SPME fiber was injected into the GC-MS device for desorbing and identifying the composition of the samples. Desorption was performed in the GC column for 2 min. The SPME fiber holder was applied for manual use, and polydimethylsiloxane (PDMS, 100 µm) fibers were obtained from Supelco Inc. (Bellefonte, PA, USA).
GC/MS analysis was performed, using the Agilent 6890N, coupled with the HP-5MS column (30m×0.25 mm, film thickness: 0.25 mm). The column temperature was maintained at 40 °C for 12 min. Afterwards, the temperature was programmed to increase to 180 °C at a rate of 10 °C per min and remained at 180 °C for 4 min. Also, the temperature of the injector and interface was set at 250 °C and 280 °C, respectively.
The flow rate of helium as the carrier gas was 1 mL/min CF. The percentages of components were calculated by electronic integration of peak areas in flame ionization detector (FID), without using response factor corrections. Linear retention indices for all the components were determined by co-injection of the samples with a solution containing homologous C8-C24 series of n-alkanes.
Identification of the extract constituents
The constituents of the extracts were identified by comparing their relative retention time and mass spectra with the Standard Wiley Library (2001) data on the GC/MS system or the data reported in the literature [11] .
Extract dilutions
For the preparation of extract dilutions, 1,280 mg of the extracts was dissolved in 1 mL of normal saline. Serial dilutions were subsequently prepared to obtain 1-128 mg/mL concentrations of the extracts (Table 1) . To prepare the MZ dilutions, 0.01280 g of the crude powder was dissolved in 10 mL of dimethyl sulfoxide (DMSO 1%), and the serial dilution was subsequently prepared to obtain MZ at 0.0009-64 µg/mL ( Table 1) .
Selection of the dilutions of the extracts and MZ was based on the initial experiments, which showed that DMSO below 1.5% could exert no effects on the growth of Candida species. In the present study, the concentration of DMSO in various dilutions was 1% or less [12] .
In vitro antifungal activity
Anti-Candida effects of fruit and leaf extracts from P. atlantica against the tested fungi were determined via broth microdilution method, according to the modified M27-A3 protocol on yeasts by the Clinical and Laboratory Standards Institute (CLSI) [13] .
Inoculum preparation for antifungal susceptibility tests
In broth microdilution method, standardized inocula (2.5-5×10 3 CFU/mL) for Candida species were prepared by turbidimetry. The stock inocula were prepared on day two for culturing Candida species, grown on SDA at 30 ˚C. Sterile normal saline solution (0.9%, 3 mL) was added to the agar slant, and the cultures were gently swabbed to dislodge the blastoconidia from Candida species.
The blastoconidia suspensions of Candida species were transferred to sterile tubes, and the volume of suspensions was adjusted to 4 mL, using sterile saline solution. The resulting suspensions were allowed to settle for 5 min at 28 ˚C. The density of suspensions was read at 530 nm and adjusted to 95% transmittance. The suspensions were diluted to 1:2000 in RPMI-1640 medium, supplemented with lglutamine (without sodium bicarbonate). The suspensions were buffered (pH=7.0) with 0.165 mol/L of morpholinepropanesulfonic acid to obtain an inoculum size of 2.5-5×10 3 CFU/Ml. 
Determination of minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC)
The MICs were determined by broth microdilution method in accordance with the CLSI M27-A3 protocol. The microdilution assay was performed in 96-well microdilution plates. Growth and sterile control wells were included for each tested extract. The microplates were incubated at 37 ˚C and read visually after 48 h. The assays were run in duplicate for all the extracts and repeated at least twice. MIC was defined as the lowest oil concentration, causing 100% inhibition of visible fungal growth. The results were read visually, as recommended by CLSI. MFCs were determined by subculturing 100 µL of the solution from the wells without turbidity on PDA at 28 ˚C. MFC was defined as the lowest concentration resulting in no growth on the subculture after two days.
Statistical analysis
SPSS version 17 (SPSS Inc., Chicago, USA) was used for data entry and statistical analysis. Differences between the extracts were determined, using one-way analysis of variance (ANOVA). P-value less than 0.05 was considered statistically significant. Tables 2 and 3 present the identified constituents of fruit and leaf extracts from P. atlantica and the percentages obtained by GC/MS analysis. The main constituents of fruit extracts were β-myrcene (41.4%), α-pinene (32.48%) and limonene (4.66%), respectively. In addition, the major constituents of leaf extracts from P. atlantica included transcaryophyllene (15.18%), α-amorphene (8.1%) and neo-allo-ocimene (6.21%), respectively.
Results
GC/MS analysis of the extracts
In vitro antifungal activities of the extracts
As presented in Table 4 , various extracts of P. atlantica demonstrated both fungistatic and fungicidal activities, with MICs ranging from 6.66 to 26.66 mg/mL and MFCs ranging from 13.3 to 37.3 mg/mL. Among the tested extracts, the methanolic extract of fresh P. atlantica fruit was significantly more effective than other evaluated extracts, as it exhibited lower MICs (range: 6.66-10.66 mg/mL) and MFCs (range: 13.3-21.3 mg/mL) for all the tested fungal strains (P<0.05). In contrast, the aqueous extract of P. atlantica leaf exhibited the least significant antifungal effects, with the highest MIC (21.33 mg/mL) and MFC (37.3 mg/mL) values. Moreover, the MICs and MFCs for MZ as the control agent against the tested yeasts ranged from 0.0013 to 0.0026 mg/mL and 0.002 to 0.004 mg/mL, respectively. The negative controls also did not show any inhibitory effects against the tested yeast strains.
The difference in the antifungal effects between the extracts and the standard drugs was not statistically significant, whereas a significant difference was detected between the methanolic fruit extract and others (P<0.05). Based on the findings, among the tested fungi, C. albicans was most sensitive to P. atlantica extracts, while C. glabrata was the most resistant yeast.
Discussion
Natural products such as plant extracts, either as pure or standardized compounds, provide unlimited opportunities for new drug discoveries, considering the unmatched availability of chemical diversity [14] . According to World Health Organization (WHO), more than 80% of the world's population relies on traditional medicines for their primary healthcare needs.
Over the past decades, advent of synthetic antimicrobials has resulted in an increasing aversion against medicinal plants as a rich resource of antimicrobial agents [15] . However, in recent years, some limitations in the use of these agents have led to some changes and attracted interest in the field of ethnobotanical research [16] .
Based on the findings of the present study, all the tested extracts indicated both fungistatic and fungicidal activities with MIC and MFC values ranging from 6.66 to 26.66 mg/mL and 13.3 to 37.3 mg/mL, respectively. Each of the evaluated extracts in the present study exhibited antifungal activities against at least one of the tested fungi. However, differences in the antifungal activities of the plant extracts indicated a broad antifungal spectrum. These variations in antifungal activity could be related to differences in the chemical composition of Miconazole (µg/mL) *The difference in the anti-fungal effects with other P. atlantica extracts was statistically significant (P<0.05) **The difference in the anti-fungal effects with other P. atlantica extracts was statistically significant (P<0.05) Data are expressed as mean values (n=3) different parts of the plant as secondary metabolites, affecting the antimicrobial properties of these parts [15] .
The activity of the plant extracts could be influenced by the nature of the plant material or its origin, climatic conditions in which the plant grows, the used plant parts and the extraction solvent [17] . In our study, the methanolic extract of fresh P. atlantica fruit significantly inhibited the growth of all tested fungi, while other extracts demonstrated weak to moderate antifungal activities.
Similarly, various studies have demonstrated the remarkable antifungal activities of various P. atlantica extracts against some pathogenic fungi including Fusarium solani, Rhizoctonia solani and Geotrichum candidum [18, 19] . The results of the present study were in agreement with previous findings, indicating the antimicrobial properties of commonly used medicinal plants, which can be used in the traditional treatment of some conditions [20] .
In this study, the major constituents of P. atlantica fruit extracts included β-myrcene (41.4%), α-pinene (32.48%) and limonene (4.66%), respectively, while the main constituents of leaf extracts were transcaryophyllene (15.18%), α-amorphene (8.1%) and neo-allo-ocimene (6.21%), respectively. However, as previously indicated, the chemical composition of the extracts depends on their species, climatic conditions, time of collection and growth stage, which alter their biological activities [21] .
The phytochemical screening of crude extracts showed the presence of terpenoids, phenols, flavonoids, fatty acids and sterols in P. atlantica [9] . The individual activities of these compounds have been previously demonstrated [15] . In addition, antifungal activities of these compounds and their derivates such aspinene, limonene, thymol and carvacrol against some pathogenic fungal strains have been confirmed [22] [23] [24] [25] . Ismail et al. [26] reported the correlation between antifungal activity and percentage of some compounds such as -pinene, limonene and -terpinene in P. atlantica. Therefore, phytoconstituents in this plant could be responsible for the anti-Candida activities, since the exact mode of action is poorly understood. Regarding the antimicrobial mechanism of some terpenoid compounds such as monoterpenes, Sikkema et al., have reported that compounds diffuse into pathogens and damage the structure of cell membranes [27] .
Other studies have related antimicrobial activities to the ability of terpenes to affect not only permeability, but also other functions of cell membranes. These compounds might cross the cell membranes, penetrate into the cells and interact with critical intracellular sites [26, 28] .
In conclusion, the findings of the present study revealed the antifungal effects of various P. atlantica extracts, particularly the fresh fruit extracts. Our results also provided scientific evidence on the use of natural plants in traditional medicine for the prevention and treatment of Candida infections.
